America Embassy in China has been committed to the global promotion activities of new technologies in. It’s a honor that we’ve invited officials from FDA of America and experts from Virocyt Co.Ltd from America to  share professional experience with us.

Virocyt is a leading company in the virus and vaccine research field, its new technology has drawn extensive attention in the global scope, such as: Merck, Novartis, Senauer Faye Basudeb, Blyngju G John and so on have all used this new technology in their research and vaccine production 

 

Time:Wesdnesday,08:30-13；00，September 10,2014.

Address: Mileage Hall, the 3^rd floor, Beijing Hilton Hotel

No.1,Dong Fang Dong road, the 3^rd right road north,Chaoyang District,Beijing.(Exit B,Liang Ma Qiao station,Line 3,metro)

Tel: (86-10) 5865 5000

Theme: Rapid quantitative virus and application on virus research and vaccine research.

Speaker and topic:

Xie Naisheng, business official from USA embassy

Topic: Opening ceremony speech

Craig Hoechstetter, vice president of the Virocyt company of America

Topic: new technology introduction and case study of the VC system in the research and production of the vaccine virus

Introduction: Vice President Craig Hoechstetter has for many years of professional experience in the virus research and  in the field of virus quantitative. He has close cooperation with and America Senauer Faye Basudeb, Merck, FDA, USA National Institutes and many other institutes, help to improve the virus quantitative process.

Dr. Ewan Plant, from FDA of America

Topic: difference between the derived vaccine source of chicken embryo and derived vaccine source of cell culture

Abstract: Ewan Dr. Plant is woking in the FDA of America.The vaccine research and review department which he began to work in since 2009 is focused on research and supervision of influenza vaccine since 2009. Dr. Plantand got his doctor degree of New Zealand University of Otago biochemistry professional degree, his published articles are related to the replication of the virus and ribosomal fidelity.

Wei Zhidong, Lanzhou Institute of biological products

Application of virus virus quantitative new technology in virus research and vaccine production 

Dr. Hao Jianwei, Zhongshan University

Title: comparison of virus repid quantitative techniques and traditional methods in PEDV research